| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| July 19th, 2007 | 41 | No |
None
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | -0.37 | -7.54 | -23.97 | 8 | 14 | 0 | 225 | 580.539 | 6 | ↓ |
| Hi High (pH 8-9.5) | -0.37 | -6.55 | -70.15 | 7 | 14 | -1 | 228 | 579.531 | 6 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| PUBCHEM_PATENT_ID | EP0196439A1; EP0314959B1; EP0317033B1; EP0352147A2; EP0373986A1; EP0373986B1; EP0455432A1; EP0455432B1; EP0681827B1; EP0691886B1; EP0695502A1; EP0702719A1; EP0797427A1; EP0799023A1; EP0971743A1; EP1014968A1; EP1032381A1; US4006261; US5501966; US5658793; U | IBM Patent Data |
| Target | Prostaglandin G/H synthase 2(P35354)&Cytochrome P450 19A1(P11511)&Transforming growth factor beta-1(P01137)&Cyclin-dependent kinase inhibitor 1(P38936)&High affinity immunoglobulin epsilon receptor subunit beta(Q01362) | Herbal Ingredients Targets |
